i'm still wondering what gerald has in store exact

i'm still wondering what gerald has in store exactly for ESS.
From what i got from the presentation, he does want to move ESS elsewhere, spin it out or do an IPO but i think for cash this time.

Because he also mentioned he wanted to get funds through the ESS program also to clean up the toxics or something similar in those kind of words, thats how i interpret it.

Maybe someone can back me up that understood it more clearly?

The way i see it now, is that if ESS gets a spinout then getting shares for it in return like the diagnostic division then that will do us no good.
So i'm guessing here that he will spinout ESS to another company in return for cash and some kind of partnership and use that cash to clean up the balance sheet for AMBS and move the pipeline further.

Gerald also mentioned:

"Reg A+, Rights Offering, and ESS IPO" (i copied this from JP from ihub but heard it too with my own ears during the presentation).

I'm clueless about what some of that means.
I really don't have a clear picture of whats going to happen with ESS and how that effects us if he does spin it out?

Hopefully someone can shed more light on the recent presentation???
Thanks!